Table 3. Significant predictors of death from all-cause, liver-related death or cirrhosis development corrected for achieving sustained viral response (SVR).
Event | Predictors | Univariate | Multivariate | |||
HR (95% CI) | p-value | HR (95% CI) | p-value | |||
Death from all causes | Baseline LSM | |||||
<10kPa | Reference | Reference | ||||
10–16.9kPa | 1.33 (0.63–2.76) | 0.446 | 1.09 (0.50–2.34) | 0.835 | ||
17-75kPa | 6 (3.55–10) | <0.005 | 3.64 (1.65–7.9) | 0.001 | ||
Baseline lnHA | 1.93 (1.59–2.36) | <0.005 | 1.37 (1.03–1.83) | 0.031 | ||
Baseline age | 1.03 (1.01–1.06) | 0.004 | NS | - | ||
Male sex | 1.66 (0.97–2.85) | 0.064 | NS | - | ||
Ever excessive alcohol use | 1.6 (0.97–2.64) | 0.063 | NS | - | ||
Ever intravenous drug use | 0.94 (0.55–1.62) | 0.830 | NS | - | ||
SVR | 0.46 (0.19–1.15) | 0.094 | 0.32 (1.03–1.83) | 0.014 | ||
Event | Predictors | Univariate | Multivariate | |||
sHR (95% CI) | p-value | sHR (95% CI) | p-value | |||
Liver-related deatha | Baseline LSM | |||||
<10kPa | Reference | Reference | ||||
10–16.9kPa | 9.5 (0.98–91.3) | 0.051 | 4.04 (0.41–39.8) | 0.176 | ||
17-75kPa | 97 (13.2–713) | <0.005 | 11 (1.22–98.6) | 0.018 | ||
Baseline lnHA | 5.2 (3.43–7.95) | <0.005 | 3.15 (1.77–5.62) | <0.005 | ||
Baseline age | 1.07 (1.03–1.11) | <0.005 | NS | - | ||
Male sex | 1.97 (0.79–4.87) | 0.144 | NS | - | ||
Ever excessive alcohol use | 1.96 (0.86–4.49) | 0.109 | NS | - | ||
Ever intravenous drug use | 2.1 (0.97–4.59) | 0.060 | NS | - | ||
SVR | 1.09 (0.67–3.22) | 0.883 | 0.69 (0.22–2.14) | 0.523 | ||
Complicationsb | Baseline LSM | |||||
<10kPa | Reference | Reference | 0.034 | |||
10–16.9kPa | 9.6 (2.5–36.6) | 0.001 | 4.3 (1.12–18.3) | 0.001 | ||
17-75kPa | 59 (17.4–200) | <0.005 | 9 (2.49–32.2) | |||
Baseline lnHA | 4.5 (3.4–5.9) | <0.005 | 2.8 (1.9–3.8) | <0.005 | ||
Baseline age | 1.07 (1.03–1.11) | <0.005 | NS | |||
Male sex | 1.59 (0.70–3.59) | 0.262 | NS | |||
Ever excessive alcohol use | 0.8 (0.39–1.66) | 0.556 | NS | |||
Ever intravenous drug use | 1.83 (0.87–3.84) | 0.113 | NS | |||
SVR | 0.84 (0.25–2.83) | 0.779 | 0.39 (0.1–1.35) | 0.189 |
aAnalysis of subpopulation of (560/591) patients with a baseline age above 30 years of age.
b subpopulation (531/591) >30 years of age and no previous complications.
HR; Hazard ratio. lnHA; natural logarithm of bHA. NS; non-significant.